Sign In
Buy ARWR
$82.00
+0.180 (+0.220%)
At Close: Jun 22, 2026
The Daily Biotech Pulse: FDA Approves Novartis Lung Cancer Drug, 2-Way Contest Emerging For Tetraphase Pharma, Dexcom To Join S&P 500
12:00am, Thursday, 07'th May 2020
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech stocks hitting 52-week highs May 6.)
Adverum Biotechnologies Inc...
Ameresco Reports First Quarter 2020 Financial Results
12:00am, Monday, 04'th May 2020
Ameresco reports first quarter 2020 financial results.
The Week Ahead In Biotech: Smid-Cap Earnings News Flow Picks Up Pace
12:00am, Sunday, 03'rd May 2020
Biotech stocks started last week on a strong note but the upward momentum slowed through the week. The week saw a slew of earnings from big pharma names, including Merck...
BRIEF-Arrowhead Pharmaceuticals Announces Retirement Of COO Bruce Given
08:32pm, Friday, 01'st May 2020
Arrowhead Pharmaceuticals Inc:
Arrowhead Pharmaceuticals Announces Retirement Of COO Bruce Given
08:00pm, Friday, 01'st May 2020Arrowhead Pharmaceuticals to Participate in Upcoming May 2020 Conferences
08:00pm, Friday, 01'st May 2020
Arrowhead will present at upcoming May 2020 investor conferences
Is Arrowhead Pharmaceuticals Close to a Cure for HBV?
11:52am, Thursday, 30'th Apr 2020
The collaboration between a pharmaceutical giant and a mid-cap biotech company may have accomplished the impossible.
Arrowhead Pharmaceuticals Inc (NASDAQ:ARWR) Stock Position Lifted by Columbus Circle Investors
10:46am, Thursday, 30'th Apr 2020
Columbus Circle Investors boosted its stake in shares of Arrowhead Pharmaceuticals Inc (NASDAQ:ARWR) by 146.7% during the first quarter, according to its most recent disclosure with the SEC. The insti
Arrowhead Pharmaceuticals (ARWR) Scheduled to Post Quarterly Earnings on Thursday
08:54am, Thursday, 30'th Apr 2020
Arrowhead Pharmaceuticals (NASDAQ:ARWR) is scheduled to announce its earnings results after the market closes on Thursday, May 7th. Analysts expect the company to announce earnings of ($0.11) per shar
Insider Selling: Arrowhead Pharmaceuticals Inc (NASDAQ:ARWR) COO Sells $940,600.00 in Stock
08:12am, Thursday, 23'rd Apr 2020
Arrowhead Pharmaceuticals Inc (NASDAQ:ARWR) COO Bruce D. Given sold 23,515 shares of the firm’s stock in a transaction on Monday, April 20th. The stock was sold at an average price of $40.00, for a
Arrowhead Pharmaceuticals Inc (NASDAQ:ARWR) Short Interest Update
07:40am, Thursday, 23'rd Apr 2020
Arrowhead Pharmaceuticals Inc (NASDAQ:ARWR) saw a large drop in short interest during the month of March. As of March 31st, there was short interest totalling 7,670,000 shares, a drop of 7.3% from the
Arrowhead Pharmaceuticals to Webcast Fiscal 2020 Second Quarter Results
11:30am, Wednesday, 22'nd Apr 2020
Arrowhead Pharmaceuticals will webcast fiscal 2020 second quarter earnings on May 7, 2020
Investors Who Bought Arrowhead Pharmaceuticals (NASDAQ:ARWR) Shares Three Years Ago Are Now Up 2293%
10:10am, Wednesday, 22'nd Apr 2020
Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) shareholders might be concerned after seeing the share price drop 21% in...
Arrowhead Pharmaceuticals Inc (ARWR) COO Bruce D Given Sold $94…,6…… of Shares
12:00am, Wednesday, 22'nd Apr 2020Arrowhead Pharmaceuticals Inc (NASDAQ:ARWR) Receives Average Recommendation of "Buy" from Analysts
10:42am, Monday, 20'th Apr 2020
Arrowhead Pharmaceuticals Inc (NASDAQ:ARWR) has received an average recommendation of “Buy” from the thirteen ratings firms that are currently covering the firm, MarketBeat Ratings reports. One an
